US Patent 10253333 DNA-binding proteins and uses thereof
Patent 10253333 was granted and assigned to Sangamo Therapeutics on April, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+328 characters)
Article
Patent abstract
Disclosed herein are polypeptides, polynucleotides encoding, cells and organisms comprising novel DNA-binding domains, including TALE DNA-binding domains. Also disclosed are methods of using these novel DNA-binding domains for modulation of gene expression and/or genomic editing of endogenous cellular sequences.
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
David Paschon0
Edward J. Rebar0
Fyodor Urnov0
Jeffrey C. Miller0
Lei Zhang0
Philip D. Gregory0
Siyuan Tan0
Edits on 31 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
102533330
Date of Patent
April 9, 2019
0Patent Application Number
157099690
Date Filed
September 20, 2017
0Patent Citations Received
Patent Primary Examiner
Edits on 7 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 26 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 10 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 25 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10253333 DNA-binding proteins and uses thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10253333
Date of patent
April 9, 2019
Patent application number
15709969
Date Filed
September 20, 2017
Patent primary examiner
Find more entities like US Patent 10253333 DNA-binding proteins and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
